Furthermore, it has also been observed that the dysregulation of PP1 activity may influence the cleavage of APP by secretases, leading to the altered production of amyloid-beta (Aβ) peptides, which results in the formation of amyloid plaques and leads to AD [20,42]. The gene discussed is APP; the disease is Alzheimer disease.